Literature DB >> 25517616

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

Liufu Deng1, Hua Liang1, Meng Xu2, Xuanming Yang2, Byron Burnette1, Ainhoa Arina1, Xiao-Dong Li3, Helena Mauceri1, Michael Beckett1, Thomas Darga1, Xiaona Huang4, Thomas F Gajewski2, Zhijian J Chen5, Yang-Xin Fu6, Ralph R Weichselbaum7.   

Abstract

Ionizing radiation-mediated tumor regression depends on type I interferon (IFN) and the adaptive immune response, but several pathways control I IFN induction. Here, we demonstrate that adaptor protein STING, but not MyD88, is required for type I IFN-dependent antitumor effects of radiation. In dendritic cells (DCs), STING was required for IFN-? induction in response to irradiated-tumor cells. The cytosolic DNA sensor cyclic GMP-AMP (cGAMP) synthase (cGAS) mediated sensing of irradiated-tumor cells in DCs. Moreover, STING was essential for radiation-induced adaptive immune responses, which relied on type I IFN signaling on DCs. Exogenous IFN-? treatment rescued the cross-priming by cGAS or STING-deficient DCs. Accordingly, activation of STING by a second messenger cGAMP administration enhanced antitumor immunity induced by radiation. Thus radiation-mediated antitumor immunity in immunogenic tumors requires a functional cytosolic DNA-sensing pathway and suggests that cGAMP treatment might provide a new strategy to improve radiotherapy.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25517616      PMCID: PMC5155593          DOI: 10.1016/j.immuni.2014.10.019

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  43 in total

1.  Ultraviolet radiation damages self noncoding RNA and is detected by TLR3.

Authors:  Jamie J Bernard; Christopher Cowing-Zitron; Teruaki Nakatsuji; Beda Muehleisen; Jun Muto; Andrew W Borkowski; Laisel Martinez; Eric L Greidinger; Benjamin D Yu; Richard L Gallo
Journal:  Nat Med       Date:  2012-07-08       Impact factor: 53.440

Review 2.  Innate immune sensing and signaling of cytosolic nucleic acids.

Authors:  Jiaxi Wu; Zhijian J Chen
Journal:  Annu Rev Immunol       Date:  2014       Impact factor: 28.527

3.  Dissection of a type I interferon pathway in controlling bacterial intracellular infection in mice.

Authors:  Juliane Lippmann; Holger C Müller; Jan Naujoks; Christoph Tabeling; Sunny Shin; Martin Witzenrath; Katharina Hellwig; Carsten J Kirschning; Gregory A Taylor; Winfried Barchet; Stefan Bauer; Norbert Suttorp; Craig R Roy; Bastian Opitz
Journal:  Cell Microbiol       Date:  2011-08-24       Impact factor: 3.715

4.  Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy.

Authors:  John Stagg; Sherene Loi; Upulie Divisekera; Shin Foong Ngiow; Helene Duret; Hideo Yagita; Michele W Teng; Mark J Smyth
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-11       Impact factor: 11.205

5.  Innate immune recognition of an AT-rich stem-loop DNA motif in the Plasmodium falciparum genome.

Authors:  Shruti Sharma; Rosane B DeOliveira; Parisa Kalantari; Peggy Parroche; Nadege Goutagny; Zhaozhao Jiang; Jennie Chan; Daniella C Bartholomeu; Fanny Lauw; J Perry Hall; Glen N Barber; Ricardo T Gazzinelli; Katherine A Fitzgerald; Douglas T Golenbock
Journal:  Immunity       Date:  2011-08-04       Impact factor: 31.745

6.  The therapeutic effect of anti-HER2/neu antibody depends on both innate and adaptive immunity.

Authors:  SaeGwang Park; Zhujun Jiang; Eric D Mortenson; Liufu Deng; Olga Radkevich-Brown; Xuanming Yang; Husain Sattar; Yang Wang; Nicholas K Brown; Mark Greene; Yang Liu; Jie Tang; Shengdian Wang; Yang-Xin Fu
Journal:  Cancer Cell       Date:  2010-08-09       Impact factor: 31.743

Review 7.  Sterile inflammation: sensing and reacting to damage.

Authors:  Grace Y Chen; Gabriel Nuñez
Journal:  Nat Rev Immunol       Date:  2010-11-19       Impact factor: 53.106

8.  Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy.

Authors:  Lionel Apetoh; François Ghiringhelli; Antoine Tesniere; Michel Obeid; Carla Ortiz; Alfredo Criollo; Grégoire Mignot; M Chiara Maiuri; Evelyn Ullrich; Patrick Saulnier; Huan Yang; Sebastian Amigorena; Bernard Ryffel; Franck J Barrat; Paul Saftig; Francis Levi; Rosette Lidereau; Catherine Nogues; Jean-Paul Mira; Agnès Chompret; Virginie Joulin; Françoise Clavel-Chapelon; Jean Bourhis; Fabrice André; Suzette Delaloge; Thomas Tursz; Guido Kroemer; Laurence Zitvogel
Journal:  Nat Med       Date:  2007-08-19       Impact factor: 53.440

9.  The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells.

Authors:  Xavier Lahaye; Takeshi Satoh; Matteo Gentili; Silvia Cerboni; Cécile Conrad; Ilse Hurbain; Ahmed El Marjou; Christine Lacabaratz; Jean-Daniel Lelièvre; Nicolas Manel
Journal:  Immunity       Date:  2013-11-21       Impact factor: 31.745

10.  STING manifests self DNA-dependent inflammatory disease.

Authors:  Jeonghyun Ahn; Delia Gutman; Shinobu Saijo; Glen N Barber
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-06       Impact factor: 11.205

View more
  597 in total

Review 1.  Molecular Pathways: Targeting the Stimulator of Interferon Genes (STING) in the Immunotherapy of Cancer.

Authors:  Leticia Corrales; Thomas F Gajewski
Journal:  Clin Cancer Res       Date:  2015-09-15       Impact factor: 12.531

Review 2.  Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications.

Authors:  Martina Musella; Gwenola Manic; Ruggero De Maria; Ilio Vitale; Antonella Sistigu
Journal:  Oncoimmunology       Date:  2017-04-05       Impact factor: 8.110

3.  Endogenous and pharmacologic targeting of the STING pathway in cancer immunotherapy.

Authors:  Leticia Corrales; Thomas F Gajewski
Journal:  Cytokine       Date:  2015-08-24       Impact factor: 3.861

Review 4.  Inhibitors of the PD-1 Pathway in Tumor Therapy.

Authors:  Martin W LaFleur; Yuki Muroyama; Charles G Drake; Arlene H Sharpe
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

5.  The Unfolded Protein Response Mediator PERK Governs Myeloid Cell-Driven Immunosuppression in Tumors through Inhibition of STING Signaling.

Authors:  Eslam Mohamed; Rosa A Sierra; Jimena Trillo-Tinoco; Yu Cao; Patrick Innamarato; Kyle K Payne; Alvaro de Mingo Pulido; Jessica Mandula; Shuzhong Zhang; Paul Thevenot; Subir Biswas; Sarah K Abdalla; Tara Lee Costich; Kay Hänggi; Carmen M Anadon; Elsa R Flores; Eric B Haura; Shikhar Mehrotra; Shari Pilon-Thomas; Brian Ruffell; David H Munn; Juan R Cubillos-Ruiz; Jose R Conejo-Garcia; Paulo C Rodriguez
Journal:  Immunity       Date:  2020-04-14       Impact factor: 31.745

Review 6.  Making Checkpoint Inhibitors Part of Treatment of Patients With Locally Advanced Lung Cancers: The Time Is Now.

Authors:  Mark G Kris; Corinne Faivre-Finn; Tiana Kordbacheh; Jamie Chaft; Jia Luo; Anne Tsao; Stephen Swisher
Journal:  Am Soc Clin Oncol Educ Book       Date:  2020-03

7.  A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment.

Authors:  Anje Cauwels; Sandra Van Lint; Geneviève Garcin; Jennyfer Bultinck; Franciane Paul; Sarah Gerlo; José Van der Heyden; Yann Bordat; Dominiek Catteeuw; Lode De Cauwer; Elke Rogge; Annick Verhee; Gilles Uzé; Jan Tavernier
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

8.  PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.

Authors:  Megan Morisada; Paul E Clavijo; Ellen Moore; Lillian Sun; Michael Chamberlin; Carter Van Waes; James W Hodge; James B Mitchell; Jay Friedman; Clint T Allen
Journal:  Oncoimmunology       Date:  2017-11-27       Impact factor: 8.110

Review 9.  DNA-stimulated cell death: implications for host defence, inflammatory diseases and cancer.

Authors:  Søren R Paludan; Line S Reinert; Veit Hornung
Journal:  Nat Rev Immunol       Date:  2019-03       Impact factor: 53.106

10.  STING Promotes Homeostasis via Regulation of Cell Proliferation and Chromosomal Stability.

Authors:  Diana Rose E Ranoa; Ryan C Widau; Stephen Mallon; Akash D Parekh; Claudia M Nicolae; Xiaona Huang; Michael J Bolt; Ainhoa Arina; Renate Parry; Stephen J Kron; George-Lucian Moldovan; Nikolai N Khodarev; Ralph R Weichselbaum
Journal:  Cancer Res       Date:  2018-11-27       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.